336 related articles for article (PubMed ID: 18669975)
1. Treatment of pediatric acute lymphoblastic leukemia.
Tucci F; Aricò M
Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
[No Abstract] [Full Text] [Related]
2. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
3. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology.
Starý J; Gajdos P; Hrstková H; Blazek B; Slavík Z; Mihál V; Zahálka F; Jabali Y; Vávra V; Kopecná L; Mydlil J; Trka J
Med Pediatr Oncol; 2002 Aug; 39(2):125-7. PubMed ID: 12116061
[No Abstract] [Full Text] [Related]
5. [Abnormally high methotrexate levels in the cerebrospinal fluid after intravenous and intrathecal treatment for acute lymphoblastic leukemia].
Négre V; Leneveu A; Chevallier B; Roux A
Arch Fr Pediatr; 1991 Jan; 48(1):63. PubMed ID: 2018429
[No Abstract] [Full Text] [Related]
6. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
7. Twelve years experience with methotrexate infusions in childhood ALL.
Moe PJ; Seip M; Wesenberg F; Kolmannskog S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():54-8. PubMed ID: 3214038
[No Abstract] [Full Text] [Related]
8. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
[TBL] [Abstract][Full Text] [Related]
9. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol].
Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM
An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045
[No Abstract] [Full Text] [Related]
10. [High-risk acute lymphoblastic leukemia].
Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
[No Abstract] [Full Text] [Related]
11. [Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol].
Bernacer M; Aracil J; Contra T; Gil C; López J; López-Ibor B; Martín N; Melero C; Valverde F; Vecilla C
An Esp Pediatr; 1988 Oct; 29 Suppl 34():68-72. PubMed ID: 3214042
[No Abstract] [Full Text] [Related]
12. Pancreatic and renal involvement in pediatric acute lymphoblastic leukemia/lymphoma.
Ikawa Y; Saikawa Y; Horisawa T; Kuroda R
J Clin Oncol; 2007 Feb; 25(4):451-3. PubMed ID: 17264344
[No Abstract] [Full Text] [Related]
13. MTHFR 677 C>T genotype and adverse outcomes in treatment of childhood ALL: is the jury in?
Goyal RK
Pediatr Blood Cancer; 2009 Mar; 52(3):316-7. PubMed ID: 19058213
[No Abstract] [Full Text] [Related]
14. Numb chin syndrome in acute lymphoblastic leukemia.
Pansy J; Lackner H; Benesch M; Urban C
Indian Pediatr; 2011 Jun; 48(6):481-3. PubMed ID: 21743114
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
[No Abstract] [Full Text] [Related]
16. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
[No Abstract] [Full Text] [Related]
17. Down syndrome and acute lymphoblastic leukaemia.
Whitlock JA
Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
[TBL] [Abstract][Full Text] [Related]
18. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
Cario G; Fetz A; Bretscher C; Möricke A; Schrauder A; Stanulla M; Schrappe M
Ann Hematol; 2008 Sep; 87(9):709-16. PubMed ID: 18521602
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics of childhood acute lymphoblastic leukemia.
Brenner TL; Pui CH; Evan WE
Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
[TBL] [Abstract][Full Text] [Related]
20. [Meningeal involvement in ALL. Comparative study of 2 methods of protecting the CNS].
Verdeguer A; Castel V; Ferris J; Esquembre C
An Esp Pediatr; 1988 Oct; 29 Suppl 34():52-3. PubMed ID: 3214037
[No Abstract] [Full Text] [Related]
[Next] [New Search]
